Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132665) titled 'An Exploratory Study of Obinutuzumab ß in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy' on Sept. 17.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Second Affiliated Hospital of the Army Medical University
Condition:
Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-25
Target Sample Size: Intervention group:24;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=339191
Published by HT Digital C...